help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published ahead of print on December 7, 2006, doi:10.1164/rccm.200608-1079OC

Am. J. Respir. Crit. Care Med., Volume 175, Number 5, March 2007, 507-513

A more recent version of this article appeared on March 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200608-1079OCv1
175/5/507    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daud, S. A
Right arrow Articles by Hachem, R. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daud, S. A
Right arrow Articles by Hachem, R. R

Submitted on August 2, 2006
Accepted on December 7, 2006

The Impact of Immediate Primary Lung Allograft Dysfunction on Bronchiolitis Obliterans Syndrome

Shiraz A Daud1, Roger D Yusen1, Bryan Meyers2, Murali M Chakinala1, Michael J Walter1, Aviva A Aloush2, G. Alexander Patterson2, Elbert P Trulock1, and Ramsey R Hachem1*

1 Division of Pulmonary & Critical Care, Washington University School of Medicine, St. Louis, MO, USA, 2 Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, MO, USA

* To whom correspondence should be addressed. E-mail: rhachem{at}im.wustl.edu.

Rationale: Primary graft dysfunction is a common complication after lung transplantation and a significant risk factor for short and long-term mortality. Objective: We examined the impact of primary graft dysfunction on bronchiolitis obliterans syndrome. Methods: We performed a retrospective cohort study of 334 adult lung transplant recipients at our program and graded the severity of primary graft dysfunction according to the International Society for Heart and Lung Transplantation definition. We evaluated the impact of primary graft dysfunction on acute rejection, lymphocytic bronchitis, and bronchiolitis obliterans syndrome stage 1 using univariable and multivariable Cox proportional hazards models. Main results: Among the 334 recipients, 65 did not have primary graft dysfunction (grade 0), 130 had grade 1, 69 had grade 2, and 70 had grade 3. In the univariable analysis, all grades of primary graft dysfunction were associated with a significantly increased risk of bronchiolitis obliterans syndrome stage 1 (grade 1: RR = 1.73, grade 2: RR = 2.13, and grade 3: RR = 2.53, compared to grade 0). The multivariable model demonstrated that the increased risk of bronchiolitis obliterans syndrome associated with primary graft dysfunction was independent of acute rejection, lymphocytic bronchitis, and community-acquired respiratory viral infections. However, there was no association between primary graft dysfunction and acute rejection or lymphocytic bronchitis. Conclusions: Primary graft dysfunction is associated with an increased risk of bronchiolitis obliterans syndrome independent of acute rejection, lymphocytic bronchitis, and community-acquired respiratory viral infections, and this risk is directly related to the severity of primary graft dysfunction.
Key words: lung transplantation, primary graft dysfunction, bronchiolitis obliterans syndrome




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
D. S. Wilkes
Primary Graft Dysfunction: It's All the RAGE
Am. J. Respir. Crit. Care Med., November 15, 2009; 180(10): 915 - 916.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. D. Christie, C. V. Shah, S. M. Kawut, N. Mangalmurti, D. J. Lederer, J. R. Sonett, V. N. Ahya, S. M. Palmer, K. Wille, V. Lama, et al.
Plasma Levels of Receptor for Advanced Glycation End Products, Blood Transfusion, and Risk of Primary Graft Dysfunction
Am. J. Respir. Crit. Care Med., November 15, 2009; 180(10): 1010 - 1015.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C. L. Lau, Y. Zhao, I. L. Kron, M. H. Stoler, V. E. Laubach, G. Ailawadi, and J. Linden
The Role of Adenosine A(2A) Receptor Signaling in Bronchiolitis Obliterans.
Ann. Thorac. Surg., October 1, 2009; 88(4): 1071 - 1078.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. Casiraghi, J. R. Tatreau, J. B. Abano, J. W. Blackwell, L. Watson, K. Burridge, S. H. Randell, and T. M. Egan
In vitro modeling of nonhypoxic cold ischemia-reperfusion simulating lung transplantation
J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 760 - 767.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Sato, S. Hirayama, D. M. Hwang, H. Lara-Guerra, D. Wagnetz, T. K. Waddell, M. Liu, and S. Keshavjee
The Role of Intrapulmonary De Novo Lymphoid Tissue in Obliterative Bronchiolitis after Lung Transplantation
J. Immunol., June 1, 2009; 182(11): 7307 - 7316.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
C. L. Lau, Y. Zhao, J. Kim, I. L. Kron, A. Sharma, Z. Yang, V. E. Laubach, J. Linden, G. Ailawadi, and D. J. Pinsky
Enhanced fibrinolysis protects against lung ischemia-reperfusion injury.
J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1241 - 1248.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
E. S. Weiss, H. C. Champion, J. A. Williams, W. A. Baumgartner, and A. S. Shah
Long-acting oral phosphodiesterase inhibition preconditions against reperfusion injury in an experimental lung transplantation model.
J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1249 - 1257.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
V. N. Lama
Update in Lung Transplantation 2008
Am. J. Respir. Crit. Care Med., May 1, 2009; 179(9): 759 - 764.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
C. Muhlfeld, I-M. Schaefer, L. Becker, C. Bussinger, M. Vollroth, A. Bosch, R. Nagib, N. Madershahian, J. Richter, T. Wahlers, et al.
Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion
Eur. Respir. J., March 1, 2009; 33(3): 625 - 633.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
J. C. Lee and J. D. Christie
Primary Graft Dysfunction
Proceedings of the ATS, January 15, 2009; 6(1): 39 - 46.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
J. A. Belperio, S. S. Weigt, M. C. Fishbein, and J. P. Lynch III
Chronic Lung Allograft Rejection: Mechanisms and Therapy
Proceedings of the ATS, January 15, 2009; 6(1): 108 - 121.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
R. D. Yusen
Technology and Outcomes Assessment in Lung Transplantation
Proceedings of the ATS, January 15, 2009; 6(1): 128 - 136.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Iwata, A. Philipovskiy, A. J. Fisher, R. G. Presson Jr., M. Chiyo, J. Lee, E. Mickler, G. N. Smith, I. Petrache, D. B. Brand, et al.
Anti-Type V Collagen Humoral Immunity in Lung Transplant Primary Graft Dysfunction
J. Immunol., October 15, 2008; 181(8): 5738 - 5747.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. Kohmoto, A. Nakao, R. Sugimoto, Y. Wang, J. Zhan, H. Ueda, and K. R. McCurry
Carbon monoxide-saturated preservation solution protects lung grafts from ischemia-reperfusion injury.
J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 1067 - 1075.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. M. Studer, M. P. George, X. Zhu, Y. Song, V. G. Valentine, M. W. Stoner, J. Sethi, C. Steele, and S. R. Duncan
CD28 Down-Regulation on CD4 T Cells Is a Marker for Graft Dysfunction in Lung Transplant Recipients
Am. J. Respir. Crit. Care Med., October 1, 2008; 178(7): 765 - 773.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
D. S. Wilkes
Clinical Year in Review III: Idiopathic Pulmonary Fibrosis, Occupational Medicine, and Lung Transplantation
Proceedings of the ATS, September 15, 2008; 5(7): 751 - 754.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. Bharat, E. Kuo, N. Steward, A. Aloush, R. Hachem, E. P. Trulock, G. A. Patterson, B. F. Meyers, and T. Mohanakumar
Immunological Link Between Primary Graft Dysfunction and Chronic Lung Allograft Rejection
Ann. Thorac. Surg., July 1, 2008; 86(1): 189 - 197.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
C. M. Burton, M. Iversen, J. Carlsen, C. Andersen, and J. Mortensen
The effect of baseline lung function on the determination of time to bronchiolitis obliterans syndrome
Eur. Respir. Rev., June 1, 2008; 17(108): 90 - 92.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. A. Corris and J. D. Christie
Update in Transplantation 2007
Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1062 - 1067.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. R. Glanville, C. L. Aboyoun, A. Havryk, M. Plit, S. Rainer, and M. A. Malouf
Severity of Lymphocytic Bronchiolitis Predicts Long-Term Outcome after Lung Transplantation
Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 1033 - 1040.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. Okazaki, A. E. Gelman, J. R. Tietjens, A. Ibricevic, C. G. Kornfeld, H. J. Huang, S. B. Richardson, J. Lai, J. R. Garbow, G. A. Patterson, et al.
Maintenance of Airway Epithelium in Acutely Rejected Orthotopic Vascularized Mouse Lung Transplants
Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 625 - 630.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society 		  ATS Clinical Skills Tests